Technology
Health
Pharmaceutical

Mustang Bio

$3.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (1.70%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Mustang Bio and other stocks, options, ETFs, and crypto commission-free!

About

Mustang Bio, Inc. Common Stock, also called Mustang Bio, is a clinical-stage biopharmaceutical company, which engages in the acquisition, development and commercialization of novel cancer immunotherapy products. Read More It offers MB-101 (IL13Ra2-specific CAR) and MB-102 (CD123 CAR). The company was founded on March 13, 2015 and is headquartered in New York, NY.

Employees
38
Headquarters
New York, New York
Founded
2015
Market Cap
97.19M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
73.37K
High Today
$3.66
Low Today
$3.40
Open Price
$3.48
Volume
10.52K
52 Week High
$11.50
52 Week Low
$2.18

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Cancer Prevention
2017 IPO
US

Earnings

Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
Actual
Available Mar 18, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.